Fifth Third Bancorp Veracyte, Inc. Transaction History

Fifth Third Bancorp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 15, 2021	SELL	$35.62 - $52.97 $196,194 - $291,758	-5,508 Closed	0 $0
Q2 2021 Aug 06, 2021	BUY	$32.94 - $56.62 $7,049 - $12,116	214 Added 4.04%	5,508 $220,000
Q1 2021 May 07, 2021	BUY	$44.47 - $81.38 $235,424 - $430,825	5,294 New	5,294 $285,000
Q2 2020 Aug 05, 2020	SELL	$19.49 - $28.11 $350 - $505	-18 Closed	0 $0
Q1 2020 May 05, 2020	BUY	$16.13 - $30.17 $290 - $543	18 New	18 $0
Q3 2019 Nov 14, 2019	SELL	$23.87 - $30.93 $1,885 - $2,443	-79 Closed	0 $0
Q2 2019 Aug 07, 2019	BUY	$22.1 - $28.56 $1,745 - $2,256	79 New	79 $2,000

308

81.8M

134K

13.3K

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $3.11B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

Get notified when there are updates to the investment portfolio of Fifth Third Bancorp, based on Form 13F filings with the SEC.

Stay updated on Fifth Third Bancorp with notifications on news.